Dual-modality PET/CT instrumentation-today and tomorrow

Eur J Radiol. 2010 Mar;73(3):452-60. doi: 10.1016/j.ejrad.2009.12.021. Epub 2010 Jan 21.

Abstract

Positron emission tomography (PET) has proven to be a clinically valuable imaging modality, particularly for oncology staging and therapy follow-up. The introduction of combined PET/CT imaging has helped address challenging imaging situations when anatomical information on PET-only was inadequate for accurate lesion localization. After a decade of PET/CT these combined systems have matured technically. Today, whole-body oncology staging is available with PET/CT in 15 min, or less. This review details recent developments in combined PET/CT instrumentation and points to implications for major applications in clinical oncology.

Publication types

  • Review

MeSH terms

  • Artifacts
  • Contrast Media
  • Equipment Design
  • Fluorodeoxyglucose F18
  • Humans
  • Image Enhancement / instrumentation
  • Image Processing, Computer-Assisted / instrumentation
  • Magnetic Resonance Imaging / instrumentation
  • Medical Oncology / instrumentation*
  • Neoplasm Staging / instrumentation
  • Positron-Emission Tomography / instrumentation*
  • Radiopharmaceuticals
  • Tomography Scanners, X-Ray Computed*
  • Whole Body Imaging / instrumentation*

Substances

  • Contrast Media
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18